Biocon
Baskaran Karunanithi has extensive work experience in the pharmaceutical industry. Baskaran started their career at Shasun Chemicals as an Assistant Manager from 2005 to 2007. Baskaran then joined Dr. Reddy's Laboratories in 2009, where they held various roles such as Associate Director and Manager until 2022. At Dr. Reddy's Laboratories, they were responsible for global quality management. In 2020, Baskaran joined Biocon Limited as the Head of the Operation Quality Team, where they verify and monitors compliance at API manufacturing sites, harmonizes practices across sites, and implements corrective actions.
Baskaran Karunanithi pursued their education in a chronological manner. In 2005, they enrolled at Madurai Kamaraj University, where they obtained a Master's degree in Chemistry in 2007. Following this, from 2010 to 2012, Baskaran attended the BITS Pilani Work Integrated Learning Programmes, earning a Master of Science (MS) degree in Quality Management. It is unknown when Baskaran completed their secondary education, but they attended St Antony's High school in Thanjavur.
In addition to their formal education, Baskaran obtained a certification in "Creating a Culture of Collaboration" from LinkedIn in September 2020.
This person is not in any teams
Biocon
21 followers
Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed and taken a range of Novel Biologics, Biosimilars, differentiated Small Molecules and affordable Recombinant Human Insulin and Analogs from Lab to Market. The Company's brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab) and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It has a pipeline of Biosimilars and Novel Biologics at various stages of development, including Insulin Tregopil, an oral insulin analog.